GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genoray Co Ltd (XKRX:122310) » Definitions » Cash Flow from Operations

Genoray Co (XKRX:122310) Cash Flow from Operations : ₩6,007 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genoray Co Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Mar. 2024, Genoray Co's Net Income From Continuing Operations was ₩2,110 Mil. Its Depreciation, Depletion and Amortization was ₩1,388 Mil. Its Change In Working Capital was ₩924 Mil. Its cash flow from deferred tax was ₩-20 Mil. Its Cash from Discontinued Operating Activities was ₩0 Mil. Its Asset Impairment Charge was ₩0 Mil. Its Stock Based Compensation was ₩0 Mil. And its Cash Flow from Others was ₩224 Mil. In all, Genoray Co's Cash Flow from Operations for the three months ended in Mar. 2024 was ₩4,627 Mil.


Genoray Co Cash Flow from Operations Historical Data

The historical data trend for Genoray Co's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genoray Co Cash Flow from Operations Chart

Genoray Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,654.99 8,507.29 15,383.29 14,836.82 3,554.57

Genoray Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,174.28 -1,256.68 1,745.71 891.27 4,626.67

Genoray Co Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Genoray Co's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

Genoray Co's Cash Flow from Operations for the quarter that ended in Mar. 2024 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,007 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genoray Co  (XKRX:122310) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Genoray Co's net income from continuing operations for the three months ended in Mar. 2024 was ₩2,110 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Genoray Co's depreciation, depletion and amortization for the three months ended in Mar. 2024 was ₩1,388 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Genoray Co's change in working capital for the three months ended in Mar. 2024 was ₩924 Mil. It means Genoray Co's working capital increased by ₩924 Mil from Dec. 2023 to Mar. 2024 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Genoray Co's cash flow from deferred tax for the three months ended in Mar. 2024 was ₩-20 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Genoray Co's cash from discontinued operating Activities for the three months ended in Mar. 2024 was ₩0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Genoray Co's asset impairment charge for the three months ended in Mar. 2024 was ₩0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Genoray Co's stock based compensation for the three months ended in Mar. 2024 was ₩0 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Genoray Co's cash flow from others for the three months ended in Mar. 2024 was ₩224 Mil.


Genoray Co Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Genoray Co's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Genoray Co (XKRX:122310) Business Description

Traded in Other Exchanges
N/A
Address
No. 512, 560, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 462-716
Genoray Co Ltd manufactures and sells medical and dental systems in South Korea. The company has developed the 3DCT software for medical and dental applications and developed innovative 3D software for dentistry. The product portfolio includes OSCAR prime, ZEN-7000, MX-600, PORT-X II, PORT-X IV, and PAPAYA.

Genoray Co (XKRX:122310) Headlines

No Headlines